Skip to content

African paediatric studies at CROI: HIV remission in children, three bnAbs in babies, two years on injectables in teens

Dr Gabriela Cromhout at CROI 2026. She is standing behind a lectern, talking into a microphone.

Vaccine fails to prevent gonorrhoea in Australian study

Professor Kate Seib at CROI 2026. She is being interviewed at the CROI conference centre.

Broadly neutralising antibody plus cabotegravir maintains viral suppression for at least a year

Dr Charlotte-Paige Rolle at CROI 2026. She is sitting down, with a small microphone in front of her.

Half the participants from placebo arm of HIV cure trial have prolonged viral load remission when given broadly neutralising antibodies

Professor John Frater at CROI 2026. He is being interviewed at the CROI conference centre.

Major US cohort reveals sharp racial disparities in HIV acquisition among trans women

Dr Sari Reisner at CROI 2026. He is being interviewed in the CROI conference centre.

People with HIV fare as well as those without it after liver transplants

Dr José Miró at CROI 2026. He is sitting down, talking into a microphone, with two people sitting to his right.

Home visits and flexible PrEP cut HIV incidence by 70% in rural Kenya and Uganda

Professor Gabriel Chamie at CROI 2026. He is standing behind a lectern, talking into a microphone.

Doravirine/islatravir non-inferior to Biktarvy as first-line treatment

Professor Jürgen Rockstroh at CROI 2026. He is talking into a microphone.

Machine learning: shortcut or short-circuit to enhanced HIV outcomes?

Dr Peter Kyalo at CROI 2026. He is talking into a microphone.